NCT03917797View on ClinicalTrials.gov

Mesenchymal Stromal Cells (MSC´s) in Renal Lupus

PHASE2RecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Lupus Erythematosus, SystemicLupus Glomerulonephritis
Interventions
BIOLOGICAL

MSC treatment

Umbilical cord-derived Mesenchymal Stromal Cell

DRUG

Standard of Care

Methylprednisolone; Cyclophosphamide; Prednisone; Mycophenolate

DRUG

Placebo

MSC infusion vehicle

Trial Locations (2)

7591278

RECRUITING

Clínica Universidad de los Andes, Santiago

Unknown

RECRUITING

Hospital Barros Luco Trudeau, Santiago

All Listed Sponsors
lead

Universidad de los Andes, Chile

OTHER